Skip to main content
. 2013 Mar 1;2(3):e23472. doi: 10.4161/onci.23472

Table 1. Patients’ characteristics and ΔΔCt cluster.

Characteristics Total
(n = 89)		 #NKp30High
(n = 20)		 #NKp30Int
(n = 42)		 #NKp30Low
(n = 23)		 Statistics    
Sex*
 p1
    
Men
 67 (75%)
 15 (75%)
 31 (74%)
 17 (74%)
 1
    
Women
 22 (25%)
 5 (25%)
 11 (26%)
 6 (26%)
    
Mode of transmission*
    
Men from Men
 31 (69%)
 13 (65%)
 27 (64%)
 17 (74%)
 0. 69
    
Men from Women
 6 (7%)
 2 (10%)
 4 (10%)
 0 (0%)
    
Women from Men
 22 (25%)
 5 (25%)
 11 (26%)
 6 (26%)
    
Time (in months) from infection to **
 p2
    
Inclusion
 6.2 [1.3–43.5]
 5.4 [2.7–41.2]
 8.9 [1.3–43.5]
 6.1 [2.1–10.1]
 0.08
    
NKp30 study
 38.3 [3.6–44.4]
 40.0 [8.5–44.0]
 28.0 [3.6–44.4]
 41.8 [17.2–44.4]
 0.008
    
Biological markers**
 p2
 p3
    
At inclusion
    
CD4+ cells
 556 [72–1330]
 458.5 [268–1260]
 542 [72–1193]
 616 [224–1330]
 0.05
 0.09a
    
Log(HIV-1 RNA)
 4.1 [2.4–5.6]
 4.3 [3.5–5.6]
 4.1 [3.1–5.3]
 3.9 [2.4–5.5]
 0.18
 0.18a
    
Log(HIV-1 DNA)
 2.8 [1.7–4.0]
 2.8 [1.8–3.6]
 2.7 [1.7–3.7]
 2.9 [1.7–4.0]
 0.57
 0.60a
    
At NKp30 status assessment
    
CD4+ cells
 478 [19–1193]
 479 [244–797]
 490 [72–1193]
 456 [19–917]
 0.60
 0.62b
    
Log(HIV-1 RNA)
 4.0 [2.4–5.6]
 3.7 [3.0–5.5]
 4.0 [3.0–5.1]
 4.0 [2.7–5.6]
 0.99
 0.99b
    
Log(HIV-1 DNA) 2.9 [1.6–5.2] 3.0 [2.0–5.2] 2.9 [1.9–3.7] 3.0 [1.6–4.0] 0.75 0.45b    

# ΔΔCt cluster groups; *number (%); **median [min-max]; 1Fisher’s exact test; 2Kruskal-Wallis rank sum test; 3Linear regression adjusted for: amean time from contamination to inclusion in the study, bmean time from contamination to NKp30 status assessment.